🇺🇸 FDA
Patent

US 11345733

Colon and pancreas cancer specific antigens and antibodies

granted A61KA61K51/1063A61P

Quick answer

US patent 11345733 (Colon and pancreas cancer specific antigens and antibodies) held by PRECISION BIOLOGICS, INC. expires Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
PRECISION BIOLOGICS, INC.
Grant date
Tue May 31 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K51/1063, A61P, A61P35/00, A61P37/04